Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Moolec Science ( (MLEC) ) has provided an update.
On September 11, 2025, Moolec Science announced significant advancements, including regulatory approval in Argentina for its safflower GLASO technology, expansion of U.S. acreage, and the appointment of a new CFO. The approval in Argentina by SENASA allows Moolec to expand its safflower crop enriched in gamma-linolenic acid, enhancing supply chain flexibility and positioning the company for commercial growth. The U.S. acreage expansion demonstrates the scalability of Moolec’s technology, increasing inventory to meet demand in the pet food and human nutrition sectors. Additionally, the appointment of Valeria Falottico as CFO aims to strengthen leadership and support the company’s growth and financial discipline. Moolec also completed the integration of Mycofood™, expanding its protein technology portfolio with fungal-based alternatives, reinforcing its position as a leader in biotechnology and food production.
The most recent analyst rating on (MLEC) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on Moolec Science stock, see the MLEC Stock Forecast page.
Spark’s Take on MLEC Stock
According to Spark, TipRanks’ AI Analyst, MLEC is a Underperform.
Moolec Science faces significant financial challenges with negative profitability and cash flow issues despite revenue growth. The technical analysis is bearish, and the valuation appears unfavorable with a negative P/E ratio. These factors contribute to a low overall stock score, highlighting the need for improved financial performance and market sentiment.
To see Spark’s full report on MLEC stock, click here.
More about Moolec Science
Moolec Science is an innovation-driven company focused on engineering plants and microbes to create scalable protein solutions for the global food industry. The company integrates Molecular Farming and precision fermentation to produce sustainable and commercially viable ingredients, including alternative proteins, bioactive compounds, nutritional oils, and biological inputs for regenerative agriculture. Moolec operates in the United States, Europe, and South America and is publicly listed on Nasdaq under the ticker ‘MLEC.’
Average Trading Volume: 140,707
Technical Sentiment Signal: Sell
Current Market Cap: $15.03M
For a thorough assessment of MLEC stock, go to TipRanks’ Stock Analysis page.